Saskia J. Santegoets
Leiden, ZH 2333ZA, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
The local cellular response to Human Papillomavirus focuses on basal layer restoration as visualized in situ by specific cellular neighborhoods near infected cells.
Journal: Frontiers in immunology
Published: October 20, 2025
High Treg and PMN-MDSC densities are a hallmark of tertiary lymphoid structures in fatal cases of cervical cancer.
Journal: Journal for immunotherapy of cancer
Published: September 08, 2025
Effective TIL Therapy for Patients with Checkpoint-Resistant Melanoma without Lymphodepleting Regimens Requires IFNα.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 23, 2024
Blood based immune biomarkers associated with clinical frailty scale in older patients with melanoma receiving checkpoint inhibitor immunotherapy.
Journal: Immunity & ageing : I & A
Published: June 06, 2024
Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: October 17, 2023
CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors.
Journal: Cellular & molecular immunology
Published: July 11, 2023
The combined HPV16-E2/E6/E7 T cell response in oropharyngeal cancer predicts superior survival.
Journal: Cell reports. Medicine
Published: May 03, 2023
The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: May 05, 2022
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S.
Journal: Journal for immunotherapy of cancer
Published: February 02, 2022
Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survival.
Journal: Journal for immunotherapy of cancer
Published: January 18, 2022
Last Updated: 09/26/2026